Tempus AI TEM jumped 7.3% at yesterday’s close after securing FDA 510(k) clearance for its ECG-Low EF software, its second greenlighted AI tool in cardiology. The approval adds fuel to a stock already ...

After a weak first half, the drug and biotech sector has recovered in the past 2-3 months with large drugmakers like Pfizer, ...

Last month’s news that a Chinese startup called DeepSeek had developed a large language model for a tiny fraction of the cost of those built by U.S. companies triggered a nearly $1 trillion selloff in ...

IonQ's third-quarter revenue came in much higher than management had previously predicted. Over the last year, IonQ has spent billions of dollars acquiring competing quantum AI businesses. For now, ...

NEW YORK, NY, UNITED STATES, September 6, 2023/EINPresswire.com/ -- Benevira recently became one of 200 companies worldwide to earn a coveted presentation slot at the ...

With momentum surging across diagnostics, data, and Artificial Intelligence (AI), Tempus AI is fast becoming a precision medicine powerhouse. For investors, now’s the time to gauge just how big this ...